Follistatin (FS-344): What the Evidence Actually Shows

You have probably seen follistatin sold as the shortcut to releasing your body's built-in brake on muscle growth. The biology behind that claim is real, and it is genuinely striking.

But there is a catch that the sales pitches skip over, and it changes the whole picture. The dramatic before-and-after science everyone points to was done one way. The vial most people actually buy and inject works a different way. Those are not the same thing, and the evidence for them is not the same either.

Here is the honest version: how it works, what the science actually shows, where the real risk sits, and how it stands legally. No hype, no flat no.

What is follistatin, and how does it work?

It releases two natural brakes on muscle at once, which is why the effect can be so large. Follistatin is a naturally occurring glycoprotein produced throughout the body, and FS-344 is the alternatively spliced isoform used in research. To see why it draws so much interest, it helps to understand the system it acts on:

• The natural brake on muscle: myostatin. Muscle does not grow without limit, and the reason is myostatin, a protein the body makes that acts like a built-in governor on muscle size, actively holding it back. Myostatin signals through the activin type IIB receptor (ActRIIB) and the downstream SMAD2/3 pathway to suppress the growth and differentiation of muscle fibers. Animals and people born with naturally low myostatin are conspicuously, heavily muscled, which is clear evidence this brake is real.
• Follistatin eases off that brake. Follistatin is a high-affinity binding protein. It binds and neutralizes myostatin directly, and it also binds activin, a second TGF-beta ligand that signals through the same receptor and adds to the same restraining tone on muscle. By mopping up both signals before they can reach the receptor, follistatin lifts the inhibitory signal and lets muscle growth and protein synthesis proceed more freely.
• The net effect is hypertrophy. Because it eases off two brakes at once rather than one, follistatin is a more complete release of this pathway than blocking myostatin alone, which is exactly why it produces such large effects in the right delivery system.

That is a coherent, well-mapped mechanism. The size of the effect, though, depends heavily on how the protein is delivered, and that is exactly where the evidence splits.

What did the striking gene-therapy research actually show?

Large, real gains, but from a method almost no one buying follistatin is using. When the FS-344 gene was delivered using an adeno-associated viral (AAV) vector, meaning the muscle is instructed to keep producing follistatin itself, the results in mouse and non-human primate models were dramatic, with large increases in muscle mass and strength.

That work then moved cautiously into humans in a disease context. A phase 1/2a follistatin gene therapy trial used AAV-delivered FS344 in patients with Becker muscular dystrophy, a muscle-wasting disease, and reported functional improvements on a walking test, with no treatment-related serious adverse events reported in the study (Mendell et al., 2015, DOI). The authors chose the alternatively spliced FS344 isoform specifically to avoid binding to off-target sites. It is a carefully conducted result, and it shows the mechanism translates from animals to people when the protein is delivered this way.

So why does the delivery method change everything?

The impressive data are for gene therapy; the injected peptide is a different intervention with still-early human evidence. The mechanism above is identical in both cases, but the delivery is not:

• Gene therapy uses a viral vector to rewire the muscle to manufacture follistatin continuously, like retooling the factory itself, so the brake stays eased over time. That is what was tested in animals and in the Becker muscular dystrophy trial.
• The injected peptide that people buy is a different intervention entirely. It drips the finished protein in from outside rather than having the muscle produce its own. As a recent review of peptide therapies noted, most published studies have focused on the gene-therapy form, not the infused peptide.

So the mechanism is sound and the gene-therapy data are genuinely impressive. The honest gap is that the strong human evidence sits with gene therapy, not the injected peptide most people are actually using.

Is follistatin safe?

The molecule looks reassuring in supervised trials; the real risk is what is in the vial you buy. In the gene-therapy trials, conducted under medical supervision in disease settings, no treatment-related serious adverse events were reported, which is reassuring as far as it goes. The injected peptide is a different context with limited human safety data, so its real-world risk profile, especially with repeated use, is not yet well defined.

For most people, the biggest practical risk has nothing to do with the molecule itself. Because follistatin is unregulated, the products people buy are not quality-controlled: you are trusting a vial from an unknown kitchen, not a licensed pharmacy. That opens the door to contamination, incorrect dosing, and impurities, which is a real concern with any compound made and sold outside a licensed pharmaceutical supply chain. It is the main reason that, for anyone choosing to use it, medical supervision and monitoring matter.

Is follistatin legal, and can athletes use it?

It is unapproved everywhere and banned in tested sport. Follistatin / FS-344 is not an approved medicine: it has no marketing approval from the US FDA, the European EMA, or Australia's TGA, so outside of approved clinical research it remains an experimental compound. That is also why the human data on the injected peptide is so limited, and the two things belong in the same sentence: with no legal route to market there is no commercial sponsor, and without a sponsor nobody funds the trial. The absence of a result is not a result. The wider picture is moving, though: in July 2026 an FDA advisory committee recommended six of the seven peptides it reviewed for legal pharmacy compounding, with five more scheduled before the end of February. Follistatin was not among them, but the direction has changed. See the July 2026 FDA peptide vote, explained. It is on the World Anti-Doping Agency Prohibited List, relevant only if you compete in a tested sport.

Our take

Genuinely interesting biology, but promising rather than proven for the injected peptide, and the real risk is product quality. The mechanism is well mapped and the gene-therapy data are striking. Still, the strong human evidence is for the gene-therapy form, so for the injected peptide most people use it is fair to call it promising rather than proven. Unproven here means untested rather than tested and failed: no sponsor has ever had a commercial reason to run that trial, because there has never been a legal route to sell it. The biggest practical risk is not the molecule but the unregulated, unverified products sold outside a licensed supply chain.

That is exactly where a doctor adds value. Follistatin is talked about a lot, but we do not sell it or prescribe it. What we offer is practical, high-end information: an honest read of what the evidence supports, how to judge product quality, and what to watch for in your own health, so that anyone considering or already using it can do so as intelligently and safely as possible, alongside the muscle and performance fundamentals that always help, namely structured resistance training, adequate protein, sleep, and treating any underlying cause of muscle loss. We are here to give you a straight, individualized view, neither hype nor a flat no. You can see how that works in our longevity clinic in Marbella. This article is educational and is not an offer to prescribe or supply follistatin.

If you want the wider context, see our full peptides guide.

A candid word on our role. We do not sell peptides, and we do not prescribe them. What we offer is rarer, and harder to buy: the knowledge to understand them properly. Many people have already decided to use a compound like this on their own terms, and for them the honest question is not whether to use it, but whether to do it blindly or intelligently. That is where we are useful. We can educate you on what the evidence genuinely supports and what it does not, on how to judge quality and sourcing, on the difference between a considered approach and a reckless one, and on what to monitor in your own body. Not a product, and not a prescription. There is no shortage of confident advice online, and much of it comes from people who will happily sell you the compound as well. What a physician adds is different in kind: a genuine understanding of the physiology, of what a molecule is actually doing inside you, whether it belongs there at all, and the point at which it stops helping and starts to harm, together with the training to recognize, diagnose and treat a complication if one arises. That is the part that matters most, because it is precisely the moment the confident voices tend to fall quiet and refer you to a doctor. We would simply rather be the doctor you begin with than the one you are sent to once something has already gone wrong.